NCT04477889

Brief Summary

This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2020

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

July 17, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2025

Completed
Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

5 years

First QC Date

July 17, 2020

Last Update Submit

May 15, 2026

Conditions

COVID-19

Outcome Measures

Primary Outcomes (3)

  • Patient Characteristics

    Patient characteristics

    June 2020 - Dec 2025

  • Treatment Measures and Intervention strategies

    Treatment measures and intervention strategies

    June 2020 - Dec 2025

  • Clinical and survival outcomes

    Clinical and survival outcomes

    June 2020 - Dec 2025

Study Arms (2)

COVID-19 Cohort

Patients treated at MHS facilites for COVID-19

Other: Treatment for COVID-19

Synopsis for COVID Bariatric, Hepato-Biliary and Colorectal surgery study

30 Day Mortality after surgery in patients with COVID19 infection who undergo elective bariatric, hepato-biliary and colorectal surgery. * Patients diagnosed with COVID-19 at the time of surgery up to seven days before surgery * Patients diagnosed with COVID-19 within 30 days after surgery

Other: Treatment for COVID-19

Interventions

Treatment for COVID-19OTHER

Patients treated for COVID-19

COVID-19 CohortSynopsis for COVID Bariatric, Hepato-Biliary and Colorectal surgery study

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients who are treated at MHS facilities for COVID-19.

You may qualify if:

  • Patient tested positive for COVID-19 (SARS-CoV-2)
  • Patient sought care for COVID-19 at a MHS facility
  • Aged 18 years or older

You may not qualify if:

  • Patient that do not have COVID-19
  • Non-confirmed COVID-19 patients
  • Aged 17 years or younger

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Research Institute Methodist Health System

Dallas, Texas, 75203, United States

Location

MeSH Terms

Conditions

COVID-19

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Crystee Cooper, DHEd

    Methodist Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2020

First Posted

July 20, 2020

Study Start

June 20, 2020

Primary Completion

June 16, 2025

Study Completion

June 16, 2025

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

US(1)